ITGB1 Drives Hepatocellular Carcinoma Progression by Modulating Cell Cycle Process Through PXN/YWHAZ/AKT Pathways

Integrin β1 (ITGB1), which acts as an extracellular matrix (ECM) receptor, has gained increasing attention as a therapeutic target for the treatment of hepatocellular carcinoma (HCC). However, the underpinning mechanism of how ITGB1 drives HCC progression remains elusive. In this study, we first fou...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jinghe, Guo, Tingting, Zhong, Zhiyong, Wang, Ning, Liang, Yan, Zeng, Weiping, Liu, Shoupei, Chen, Qicong, Tang, Xianglian, Wu, Haibin, Zhang, Shuai, Ma, Keqiang, Wang, Bailin, Ou, Yimeng, Gu, Weili, Chen, Honglin, Qiu, Yaqi, Duan, Yuyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718767/
https://www.ncbi.nlm.nih.gov/pubmed/34977001
http://dx.doi.org/10.3389/fcell.2021.711149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718767/
https://www.ncbi.nlm.nih.gov/pubmed/34977001
http://dx.doi.org/10.3389/fcell.2021.711149

Ejemplares similares